MOUNTAIN VIEW, Calif., Dec. 18 /PRNewswire-FirstCall/ -- IRIDEX Corporation (Nasdaq: IRIX) announced today the appointment of Ruediger Naumann-Etienne to its Board of Directors. "Rudi brings to our Board 25 years of experience in growing medical device companies," said Theodore A. Boutacoff, President and CEO of IRIDEX, "beginning in the investment banking field with Hambrecht & Quist followed by CEO/President positions with Diasonics, OEC Medical Systems and Quinton Cardiology Systems. Rudi has also made contributions on a number of public company boards including Bio-Rad Laboratories (BIO), Varian Medical Systems (VAR), Encision (ECIA) and Laserscope (LSCP). We believe his medical device industry and operational experience will be valuable to IRIDEX and look forward to his contributions."
